Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
Primary Purpose
Osteoarthritis
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hip Fracture reduction Screw without HA Coating (Hiploc)
Hip Fracture reduction Screw with HA Coating (Hiploc)
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Patients with trochanteric femoral fractures
Exclusion Criteria:
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Screw without HA Coating (Hiploc)
Screw with HA Coating (Hiploc)
Arm Description
Outcomes
Primary Outcome Measures
Harris Hip Score
Secondary Outcome Measures
DEXA
RSA
Complications
Full Information
NCT ID
NCT00756431
First Posted
September 19, 2008
Last Updated
June 16, 2017
Sponsor
Zimmer Biomet
Collaborators
Hvidovre University Hospital, Biomet U.K. Ltd.
1. Study Identification
Unique Protocol Identification Number
NCT00756431
Brief Title
Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
Official Title
Prospective Randomized Double Blinded Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
Study Type
Interventional
2. Study Status
Record Verification Date
June 2017
Overall Recruitment Status
Withdrawn
Why Stopped
No data so far
Study Start Date
January 2004 (undefined)
Primary Completion Date
June 2010 (Actual)
Study Completion Date
June 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zimmer Biomet
Collaborators
Hvidovre University Hospital, Biomet U.K. Ltd.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Evaluated whether HA coated dynamic hip screws can improve the surgical results in trochanteric femoral fractures
Detailed Description
Randomised study to determine the effect of HA coating on the stability of lag screws used to reduce femoral neck fractures. Stability of the screw will be determined by RSA measurements. The effect of the HA coating on bone remodeling will be determined by DEXA measurements
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Screw without HA Coating (Hiploc)
Arm Type
Active Comparator
Arm Title
Screw with HA Coating (Hiploc)
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Hip Fracture reduction Screw without HA Coating (Hiploc)
Other Intervention Name(s)
Hiploc
Intervention Description
Hip Fracture reduction Screw without HA Coating (Hiploc)
Intervention Type
Device
Intervention Name(s)
Hip Fracture reduction Screw with HA Coating (Hiploc)
Other Intervention Name(s)
Hiploc
Intervention Description
Hip Fracture reduction Screw with HA Coating (Hiploc)
Primary Outcome Measure Information:
Title
Harris Hip Score
Time Frame
3months, 6 months
Secondary Outcome Measure Information:
Title
DEXA
Time Frame
3months, 6 months
Title
RSA
Time Frame
3months,6 months
Title
Complications
Time Frame
Anytime
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with trochanteric femoral fractures
Exclusion Criteria:
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hendrik Palm, MD
Organizational Affiliation
Hvidovre Univ. Hospital
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures
We'll reach out to this number within 24 hrs